Seuraa
Kastritis Efstathios  OR Castritis Efstathios
Kastritis Efstathios OR Castritis Efstathios
Vahvistettu sähköpostiosoite verkkotunnuksessa med.uoa.gr
Nimike
Viittaukset
Viittaukset
Vuosi
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
SV Rajkumar, MA Dimopoulos, A Palumbo, J Blade, G Merlini, MV Mateos, ...
The lancet oncology 15 (12), e538-e548, 2014
50082014
BET bromodomain inhibition as a therapeutic strategy to target c-Myc
JE Delmore, GC Issa, ME Lemieux, PB Rahl, J Shi, HM Jacobs, E Kastritis, ...
Cell 146 (6), 904-917, 2011
30982011
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
S Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ...
The lancet oncology 17 (8), e328-e346, 2016
25042016
Hematological findings and complications of COVID‐19
E Terpos, I Ntanasis‐Stathopoulos, I Elalamy, E Kastritis, TN Sergentanis, ...
American journal of hematology 95 (7), 834-847, 2020
21282020
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors
A Bamias, E Kastritis, C Bamia, LA Moulopoulos, I Melakopoulos, ...
J Clin Oncol 23 (34), 8580-7, 2005
16072005
New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes
G Palladini, A Dispenzieri, MA Gertz, S Kumar, A Wechalekar, ...
J Clin Oncol 30 (36), 4541-4549, 2012
9342012
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid
MA Dimopoulos, E Kastritis, C Bamia, I Melakopoulos, D Gika, M Roussou, ...
Annals of Oncology 20 (1), 117-120, 2009
5772009
Organ-specific manifestations of COVID-19 infection
M Gavriatopoulou, E Korompoki, D Fotiou, I Ntanasis-Stathopoulos, ...
Clinical and experimental medicine 20, 493-506, 2020
5292020
A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis
AD Wechalekar, SO Schonland, E Kastritis, JD Gillmore, MA Dimopoulos, ...
Blood, The Journal of the American Society of Hematology 121 (17), 3420-3427, 2013
5012013
Diagnosis of monoclonal gammopathy of renal significance
F Bridoux, N Leung, CA Hutchison, G Touchard, S Sethi, JP Fermand, ...
Kidney international 87 (4), 698-711, 2015
4742015
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
N Leung, F Bridoux, V Batuman, A Chaidos, P Cockwell, VD D’Agati, ...
Nature Reviews Nephrology 15 (1), 45-59, 2019
4662019
Pathogenesis and treatment of renal failure in multiple myeloma
MA Dimopoulos, E Kastritis, L Rosinol, J Bladé, H Ludwig
Leukemia 22 (8), 1485-1493, 2008
4652008
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid
MA Dimopoulos, E Kastritis, A Anagnostopoulos, I Melakopoulos, D Gika, ...
haematologica 91 (7), 968-971, 2006
4632006
International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment
MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ...
Journal of Clinical Oncology 34 (13), 1544-1557, 2016
4392016
European Myeloma Network guidelines for the management of multiple myeloma-related complications
E Terpos, M Kleber, M Engelhardt, S Zweegman, F Gay, E Kastritis, ...
haematologica 100 (10), 1254, 2015
4072015
Daratumumab-based treatment for immunoglobulin light-chain amyloidosis
E Kastritis, G Palladini, MC Minnema, AD Wechalekar, A Jaccard, HC Lee, ...
New England Journal of Medicine 385 (1), 46-58, 2021
3662021
How I treat monoclonal gammopathy of renal significance (MGRS)
JP Fermand, F Bridoux, RA Kyle, E Kastritis, BM Weiss, MA Cook, ...
Blood, The Journal of the American Society of Hematology 122 (22), 3583-3590, 2013
3642013
Emerging treatment strategies for COVID-19 infection
M Gavriatopoulou, I Ntanasis-Stathopoulos, E Korompoki, D Fotiou, ...
Clinical and experimental medicine 21, 167-179, 2021
3592021
Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis
E Kastritis, AD Wechalekar, MA Dimopoulos, G Merlini, PN Hawkins, ...
J Clin Oncol 28 (6), 1031-1037, 2010
3492010
Phase 3 trial of ibrutinib plus rituximab in Waldenström’s macroglobulinemia
MA Dimopoulos, A Tedeschi, J Trotman, R García-Sanz, D Macdonald, ...
New England journal of medicine 378 (25), 2399-2410, 2018
3252018
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20